secwatch.observer — SEC 8-K summary
======================================

Issuer:     CapForce Inc. (CFOR)
CIK:        0001293818
Form:       8-K
Filed at:   2023-08-10T23:59:59+00:00
Accession:  0001079973-23-001113
Event type: earnings
Sentiment:  negative
Materiality: 0.90
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OpGen Q2 revenue $0.7M; cash only through Sep 2023; going concern doubt
-----------------------------------------------------------------------

- Q2 2023 revenue $0.7M vs $1.0M in Q2 2022 (prior year had one-time sale); H1 2023 revenue up 15% to $1.65M.
- Operating expenses $5.9M in Q2 (down from $6.2M); H1 $11.9M vs $12.6M year-over-year.
- Cash $3.2M at June 30, 2023; expects cash insufficient beyond Sep 2023; substantial doubt about going concern.
- Business milestones: FIND collaboration extension, Fisher Healthcare distribution for Unyvero A50 in U.S., FDA De Novo submission for UTI panel under review.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1293818/000107997323001113/0001079973-23-001113-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1293818/000107997323001113/opgen_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-23-001113

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer